
Abstract The early postpartum period is a time of intense metabolic and physiological stress as maternal recovery from pregnancy impacts immune, cardiometabolic and gastrointestinal health. Studies considering the effect of nutrition on key maternal health parameters at this critical period are lacking. A combined supplement of bovine casein hydrolysate and yeast β-glucan has been shown to improve growth, intestinal health and inflammation in animal models, but studies in humans, including early postpartum lactating women, are lacking. In this 4-week randomised controlled trial, breastfeeding women ( n 58) at 4-weeks postpartum consumed a supplement containing either: 1) a combination of 250 mg casein hydrolysate (LFC16) and 250 mg yeast β-glucan (Wellmune®) or 2) a maltodextrin control. Gastrointestinal health was self-assessed using the Structured Assessment of Gastro-Intestinal Symptoms (SAGIS) tool. At baseline, mothers reported an issue with constipation (56.5%), difficulty with defaecation (58.7%), an urgency to defaecate (6.7%), or diarrhoea (6.7%). In response to intervention, cytokine expression in peripheral blood mononuclear cells (PBMCs) and cardiometabolic health were unchanged following supplementation. After 4-weeks the intervention improved constipation domain scores ( P = 0.049) and was almost twice as likely to improve SAGIS total domain score (80.0%) compared to control (45.5%, P = 0.011). This work highlights the residual effects of pregnancy on maternal gastrointestinal health parameters in the early postpartum period, and the potential of a combined casein hydrolysate and yeast β-glucan to improve gastrointestinal health, although limited findings on inflammation were observed. Further studies in larger sample sizes are warranted.
Abstract Infant and young child feeding (IYCF) is essential for growth and cognitive development. In rural Eastern Cape (South Africa), many infants/young children consume maize from an early age, reducing food security and safety. This baseline report informed the development of a culturally-specific IYCF education program grounded in behaviour-change principles and the Health Belief Model. A cross-sectional study included 178 mother/caregiver and child pairs. A socio-demographic and 24-h dietary recall questionnaire was administered, and anthropometric measurements were taken. Most mothers/caregivers were unmarried, unemployed, and had not completed high school, relying on government grants. Household income was low, with limited access to safe water and sanitation. Stunting (20.9%) and overweight (14%) were prevalent. Exclusive breastfeeding was low (30%), early maize introduction was common (58%), and only 3.7% of children (6–24 months) achieved minimal dietary diversity. Findings indicated the need for culturally specific, behaviour-informed IYCF education to improve feeding practices, food safety, and security.
Abstract Vitamin D may help reduce the risk of colorectal cancer (CRC) by exerting an anti-inflammatory or modulatory effect on biomarkers associated with the disease. While previous studies have investigated individual biomarkers, our approach evaluates their combined effects. We investigated the association between 25-hydroxyvitamin D (25(OH)D) levels, measured using MS, and the expression of 92 inflammatory biomarkers assessed using the Olink Target 96 inflammation panel. This analysis was conducted in women from the Norwegian Women and Health Study (NOWAC), utilising plasma samples taken 1–6 years prior to CRC diagnosis ( n = 163) and 163 matched cancer-free controls. Factor analysis was used to identify biomarker patterns, and linear regression examined the association of each factor with 25(OH)D levels. Women with 25(OH)D deficiency (≤30 nmol/L) had significantly higher Factor 1 scores compared to those with sufficient levels (≥50 nmol/L) (β = 0.72, 95% CI: 0.26–1.18). This association was specific to pre-diagnostic CRC cases (β = 0.97, 95% CI: 0.33–1.60) and was not observed in cancer-free controls (β = 0.22, 95% CI: −0.50–0.93). Factor 1 represents a cluster of biomarkers, many of which are pro-inflammatory (TNFSF14, S100-A12, IL-8, IL-18) and many that play key roles in processes such as cell growth, angiogenesis, and apoptosis (OSM, TGF-alpha, VEGF-A, CASP-8). Several of these biomarkers have been independently linked to CRC, exhibiting both unfavourable and favourable roles. The observed association between 25(OH)D deficiency and Factor 1 in pre-diagnostic CRC cases supports the hypothesis that sufficient levels of vitamin D could potentially contribute to prevention of CRC development.
Abstract Household food (HFI) and water insecurity (HWI) have each been linked to poorer child health but their joint relationship is understudied. We used 2023–2024 Ecuadorian National Infant Malnutrition Survey data to examine the independent and joint associations of HFI and HWI exposure with illness, anaemia, and malnutrition in 6–59 month olds. The Food Insecurity Experience Scale measured marginal and moderate–severe HFI. Water indicators (source, availability, accessibility, microbial safety) measured HWI. We used a 4-category indicator to classify HFI only, HWI only, joint HFI/HWI, and secure food and water. Child respiratory (RI) and diarrheal illness (DI) were assessed from caregiver reports, anaemia from blood haemoglobin, and nutrition indicators from anthropometric measurements. Modified Poisson regression models estimated adjusted prevalence ratios (aPR). Joint HFI/HWI was associated with a higher RI and DI prevalence, HFI only with higher RI, stunting and overweight/obesity, and HWI only with higher overweight/obesity but lower anaemia. The age-stratified analyses linked joint HFI/HWI and HFI only to higher RI and DI in 6–23 month olds and higher RI in 24–59 month olds. Joint HFI/HWI and HWI were linked to lower anaemia. In 24–59 month olds, HFI only was associated with higher stunting and HWI only with higher overweight/obesity. Exclusion of marginal HFI in the sensitivity analysis identified child-level double malnutrition as more prevalent in 24–59 month olds from HFI only or joint HFI/HWI households. These findings suggest HFI and HWI independently and jointly influence child health and nutrition, underscoring the need for effective multisectoral policies and interventions simultaneously targeting both.
Abstract Happy Healthy Homes is a randomised controlled trial (RCT) studying the efficacy of in-person and virtual interventions on family child care home (FCCH) providers’ nutrition practices, self-efficacy, and Child and Adult Care Food Program (CACFP) knowledge. FCCH were randomly assigned to the intervention (NUT) or attention control (CON). Cohort1 (in-person 2017–2018) included 45 (NUT n = 24; CON n = 21) FCCHs. Cohort2 (virtual 2020) included 36 (NUT n = 15; CON n = 21) FCCHs. Outcomes included self-reported nutrition practices, confidence, barriers, and CACFP best practice knowledge. Measures were collected at 3 and 12 months. The primary 12-month analyses accounted for intent-to-treat and used a mixed model on all providers with 3-month outcomes including those who withdrew prior to 12-month assessments. At 12 months, both cohorts demonstrated significant effects. In Cohort1, NUT improved self-reported beverages provided and feeding environment, and confidence in serving healthy foods, while CON remained unchanged. No changes were observed for CACFP best practice knowledge. In Cohort2, NUT did not demonstrate a group effect over time for self-reported nutrition practices. NUT did increase confidence in serving healthy foods and decreased barriers related to food waste, whole grain service, children’s healthy eating habits, and CACFP best practice knowledge while CON experienced minimal changes. This study demonstrated that in-person and virtual interventions can help FCCHs improve their nutrition practices, confidence, and barriers in serving optimal foods, and knowledge in CACFP best practices. The utilisation of virtual interventions may increase reach in rural areas and be appealing to FCCH providers. Trial Registration: Clinicaltrials.gov, NCT03560050. Retrospectively registered on 23 May 2018. First participant enrolled October 2017. Trial protocol and analyses plan can be accessed on clinicaltrials.gov.